Novozymes

HQ
Hovedstaden
Total Offices: 3
3,710 Total Employees

What's It Like to Work at Novozymes?

Updated on May 30, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Novozymes and has not been reviewed or approved by Novozymes.

What's it like to work at Novozymes?

Strong purpose alignment and collaborative norms within a scaled, financially healthy platform are tempered by ongoing integration work and uneven advancement and management in some locations. Together, these dynamics suggest meaningful, stable work for many roles, with experiences varying by team and site during the post‑merger period.

Key Insight for Candidates

Post‑merger reality: Novozymes + Chr. Hansen now operate as Novonesis, where a purpose‑driven, Nordic culture meets ongoing integration. Expect meaningful biosolutions work alongside evolving org charts, consolidated functions, and consensus‑paced decisions. Success favors candidates comfortable with change who value scale and sustainability.

Evidence in Action

  • Culture Commitments And Surveys Official Culture Commitments—Explore, Impact, Ownership, Care—and frequent engagement surveys are documented mechanisms guiding behavior. They set shared expectations, surface issues quickly, and help employees experience a collaborative, respectful environment with clear feedback loops.
  • Post‑Merger Integration Cadence The Novozymes–Chr. Hansen merger (effective January 29, 2024) and reported 12.4% turnover in 2024 signal ongoing integration, reorgs, and process harmonization. Employees should expect evolving structures and tools, making adaptability and proactive communication essential to navigate role changes and decision paths.

Positive Themes About Novozymes

  • Mission & Purpose: Work centers on enzymes and microbial biosolutions that decarbonize and improve processes across many industries, which many people find meaningful. Purpose and sustainability commitments are explicit in company strategy and careers messaging.
  • Market Position & Stability: Post‑merger updates indicate a healthy platform with continued growth and investment momentum. Global scale and a meaningful U.S. footprint provide breadth across R&D, manufacturing, and commercial roles.
  • Work-Life Balance: Office and R&D roles are often described as having reasonable balance with supportive norms. Balance is role‑ and site‑dependent, with manufacturing environments following shift‑based patterns.

Considerations About Novozymes

  • Change Fatigue: The merger completed in 2024 continues to bring evolving structures, systems, and processes. Teams can experience reorgs, portfolio harmonization, and tooling changes as the combined company defines a unified culture.
  • Career Stagnation: Progression can depend on site, business unit, and function, with some locations offering limited advancement without relocation. Career velocity tends to be slower in a mature, matrixed organization.
  • Weak Management: Experiences vary by site, with local management quality and communication described as inconsistent in some locations. Decision cycles can feel slow and consensus‑driven, adding friction for teams seeking faster moves.
NEW
What does AI tell candidates about your employer brand?
Get your free AI reputation report today.
See AI Report
AI Report
AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.
Is This Your Company? Claim Profile